Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2249|181|3|441-450

ISSN： 0009-9104

Source： CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol.181, Iss.3, 2015-09, pp. : 441-450

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Streptococcus pneumoniae antibody titres in patients with primary antibody deficiency receiving intravenous immunoglobulin (IVIG) compared to subcutaneous immunoglobulin (SCIG)

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 182, Iss. 1, 2015-10 ,pp. : 51-56

John Wiley & Sons Inc

Access to resources Recommend Favorite

Symptomatic Primary Selective Immunoglobulin M Deficiency with Nonprotective Pneumococcal Titers Responsive to Subcutaneous Immunoglobulin Treatment

By  

International Archives of Allergy and Immunology, Vol. 170, Iss. 2, 2016-08 ,pp. : 138-140

Karger

Access to resources Recommend Favorite

Efficacy of Intravenous Gammaglobulin for Immunoglobulin G Subclass and/or Antibody Deficiency in Adults

By  

International Archives of Allergy and Immunology, Vol. 149, Iss. 3, 2009-02 ,pp. : 267-274

Karger

Access to resources Recommend Favorite

Immunoglobulin Replacement Therapy in Primary Antibody Deficiency Diseases – Maximizing Success

By  

International Archives of Allergy and Immunology, Vol. 136, Iss. 3, 2005-03 ,pp. : 217-229

Karger

Access to resources Recommend Favorite

Efficacy and tolerability of intramuscular interferon beta-1a compared with subcutaneous interferon beta-1a in relapsing MS: results from PROOF

By Minagara Alireza   Murray T. Jock    

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1049-1055

Informa Healthcare

Access to resources Recommend Favorite